EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Translational research in viral hepatitis: Addressing the gaps for cure23-25 January,2020 Athens
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P02-01 | Efficacy and safety of elbasvir/grazoprevir treatment in treatment-experienced and co-morbid HCV GT1b patients | Pavel Bogomolov |  Received |
 |
|||
| P01-01 | Filling the gaps: HCV treatment at a needle exchange program in Sweden (project Actionne) | Marianne Alanko | Received |
|
|||
| P06-01 | Metabolic programming of exhausted CD8 T cells in chronic viral hepatitis | Frances Winkler | Received |
|
|||
| P04-01 | The role of sphingolipids as potential biomarkers of failure to direct acting antiviral therapy in chronic HCV infection | Aissa Rhrig | Received |
|
|||
| P05-01 | Targeting hepatitis B virus with CRISPR/Cas9 | Maria Guadalupe Martinez | Received |
|
|||
| P03-01 | Therapy of hepatitis C in people who inject drugs: focus on adherence | Sona Frankova | Received |
|
|||
| P04-02 | Hepatitis C virus dysregulates polyamine and proline metabolism and perturbs urea cycle | Alexander Ivanov | Received |
|
|||
| P05-02 | Reaching people who inject drugs most in need for HCV testing, diagnosis and linkage to care through a community-based program in Athens, Greece (ARISTOTLE HCV-HIV) | Sotiris Roussos | Received |
|
|||
| P02-02 | hepatitis e virus infection among people living with hiv / aids virus in kano state | Lawal Dahiru | Received |
|
|||
| P06-02 | A transient early HBV DNA increase during PEG-IFNa therapy of hepatitis D is associated with subsequent HDV RNA response and HBsAg loss | Olympia Anastasiou | Received |
|
|||
| P03-02 | Development of Bipolymer based novel Nanoparticles in Microsphere system as vaccine adjuvant | Prakash Gosain | Received |
|
|||
| P01-02 | Development and Characterization of Oral combination vaccine against Hepatitis B and Influenza | Mani Bhargava | Received |
|
|||
| P04-03 | HCV course, efficacy and safety of DAA treatment in patients with inherited blood disorders | Abdourahman Jallow | Received |
|
|||
| P05-03 | Homocysteine mediated oxidative stress is detrimental for pregnancy complications and outcome in Hepatitis E virus infected cases: A northeast Indian patients based study | Diptika Tiwari | Received |
|
|||
| P03-03 | Lipid based Nanoparticulate system for effective vaccine delivery | Priyanka Gosain | Received |
|
|||
| P01-03 | Antibody coated Liposomes for Transmucosal Vaccination | Saurabh Bhargava | Received |
|
|||
| P02-03 | HCV treatment with DAA in children and adolescents in Russian Federation (single center study) | Elena Egorova | Received |
|
|||
| P06-03 | A CRISPR/Cas9 screen to identify host factors required for the hepatitis E virus life cycle | Noémie Oechslin | Received |
|
|||
| P01-04 | Prevalence of hepatitis C virus infection among men who have sex with men in Moscow | Pavel Bogomolov | Received |
|
|||
| P05-04 | Potential usefulness of chicken egg yolk immunoglobulins for immunotherapy of hepatitis b | Livia Villar | Received |
|
|||
| P06-04 | Hepatitis b virus x protein is required for viral gene expression, indirectly controls cccdna amplification and is dispensable for dna synthesis | Amir Shlomai | Received |
|
|||
| P04-04 | After the achivement of sustained virological response by direct acting antivirals, does the age influence the recovery of the hepatic reserve? | Yoshiyasu Karino | Received |
|
|||
| P03-04 | An undetected Hepatitis C outbreak preceded the 2011 HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study | Ilias Gountas | Received |
|
|||
| P02-04 | hepatitis b infection: is it a real public health threat in upper Egypt? | Mahmoud S. Elzalabany | Received |
|
|||
| P03-05 | The impact of treatment emerging resistance associated substitution on outcomes of re-treatment using new generation HCV treatments: Nation-wide real world analysis | Yael Gozlan | Received |
|
|||
| P02-05 | Clinicopathologic Characteristics of Follicular Lymphoma in Hepatitis C Virus-Infected Patients | Harrys Torres | Received |
|
|||
| P01-05 | health-related quality of life evaluation using questionnaires in patients with chronic hepatitis c virus infection before receiving direct-acting antivirals treatment | Raluca Dirtu | Received |
|
|||
| P05-05 | Molecular analysis of HCV subtype 1a dispersal patterns among inmates in Greece: HCV transmissions are not related to incarceration | Evangelia-Georgia Kostaki | Received |
|
|||
| P06-05 | Type I interferon exposure augments follicular T helper cell phenotype and functionality | Katharina Zoldan | Received |
|
|||
| P06-06 | Prospective study of HBV cccDNA kinetics in a French multicenter cohort of liver transplant patients (ECOGREFFE) reveals very early graft infection despite NUCHBIG prophylaxis | Franois Villeret | Received |
|
|||
Translational research in viral hepatitis: Addressing the gaps for cure
23-25 January,2020 Athens
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 23/01/2020 TO 23/01/2021
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
